No abstract available
MeSH terms
-
Clinical Trials as Topic
-
Diabetes Mellitus, Type 2 / complications
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Glucagon-Like Peptide 1 / adverse effects
-
Glucagon-Like Peptide 1 / therapeutic use*
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use
-
Obesity / complications
-
PPAR gamma / agonists
-
Pancreatic Neoplasms / epidemiology
-
Risk Assessment
-
Safety
Substances
-
Hypoglycemic Agents
-
PPAR gamma
-
Glucagon-Like Peptide 1